Loading patent…
AssigneeFresenius Kabi Deutschland GmbH
InventorsMelanie DENKINGER, Ewald SCHLOTZER, Edmundo BRITO DE LA FUENTE, Lida A. QUINCHIA-BUSTAMANTE, Crispulo GALLEGOS-MONTES
Estimating the term…
The present disclosure relates to lipid emulsions for parenteral administration, comprising 10 to 30% of a lipid phase comprising soybean oil, medium-chain triglycerides (MCT), olive oil and fish oil and less than 25 mg, preferably less than 20 mg, campesterol, less than 30 mg, preferably less than 25 mg, stigmasterol and less than 120 mg, preferably less than 100 mg, beta-sitosterol per 100 g of the lipid phase. The present disclosure also relates to the lipid emulsions according to the present disclosure for providing parenteral nutrition, in particular to neonates, as well as to methods for manufacturing the lipid emulsions according to the present disclosure.
A lipid emulsion for parenteral administration comprising an aqueous phase and 10 to 30% of a lipid phase based on the total volume of the emulsion (w/v), wherein the lipid phase comprises 20 wt. % to 40 wt. % soybean oil, 20 wt. % to 40 wt. % medium-chain triglycerides, 15 wt. % to 35 wt. % olive oil, and 1-15 wt. % fish oil extract, wherein the lipid phase comprises less than 25 mg campesterol, less than 30 mg stigmasterol and less than 120 mg beta-sitosterol per 100 g of the lipid phase,
Dependencies are inferred from the claim text.